Literature DB >> 36057834

GBA1 and The Immune System: A Potential Role in Parkinson's Disease?

Zaid A M Al-Azzawi1,2, Saman Arfaie1, Ziv Gan-Or3,4,5.   

Abstract

It is clear that the immune system and inflammation have a role in Parkinson's disease (PD), including sporadic PD and some genetic forms such as LRRK2-associated PD. One of the most important genes associated with PD is GBA1, as variants in this gene are found in 5-20% of PD patients in different populations worldwide. Biallelic variants in GBA1 may cause Gaucher disease, a lysosomal storage disorder with involvement of the immune system, and other lines of evidence link GBA1 to the immune system and inflammation. In this review, we discuss these different pieces of evidence and whether the interplay between GBA1 and the immune system may have a role in PD.

Entities:  

Keywords:  GBA1; Gaucher disease; Parkinson’s zzm321990disease; immune response; inflammation

Mesh:

Substances:

Year:  2022        PMID: 36057834      PMCID: PMC9535551          DOI: 10.3233/JPD-223423

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.520


  102 in total

1.  Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.

Authors:  Roy N Alcalay; Oren A Levy; Cheryl C Waters; Stanley Fahn; Blair Ford; Sheng-Han Kuo; Pietro Mazzoni; Michael W Pauciulo; William C Nichols; Ziv Gan-Or; Guy A Rouleau; Wendy K Chung; Pavlina Wolf; Petra Oliva; Joan Keutzer; Karen Marder; Xiaokui Zhang
Journal:  Brain       Date:  2015-06-27       Impact factor: 13.501

2.  SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's disease.

Authors:  Roy N Alcalay; Victoria Mallett; Benoît Vanderperre; Omid Tavassoly; Yves Dauvilliers; Richard Y J Wu; Jennifer A Ruskey; Claire S Leblond; Amirthagowri Ambalavanan; Sandra B Laurent; Dan Spiegelman; Alexandre Dionne-Laporte; Christopher Liong; Oren A Levy; Stanley Fahn; Cheryl Waters; Sheng-Han Kuo; Wendy K Chung; Blair Ford; Karen S Marder; Un Jung Kang; Sharon Hassin-Baer; Lior Greenbaum; Jean-Francois Trempe; Pavlina Wolf; Petra Oliva; Xiaokui Kate Zhang; Lorraine N Clark; Melanie Langlois; Patrick A Dion; Edward A Fon; Nicolas Dupre; Guy A Rouleau; Ziv Gan-Or
Journal:  Mov Disord       Date:  2019-02-20       Impact factor: 10.338

3.  Clinical and biochemical differences in patients having Parkinson disease with vs without GBA mutations.

Authors:  Lama M Chahine; Judy Qiang; Emily Ashbridge; James Minger; Dora Yearout; Stacy Horn; Amy Colcher; Howard I Hurtig; Virginia M-Y Lee; Vivianna M Van Deerlin; James B Leverenz; Andrew D Siderowf; John Q Trojanowski; Cyrus P Zabetian; Alice Chen-Plotkin
Journal:  JAMA Neurol       Date:  2013-07       Impact factor: 18.302

4.  Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia.

Authors:  Changyoun Kim; Dong-Hwan Ho; Ji-Eun Suk; Sungyong You; Sarah Michael; Junghee Kang; Sung Joong Lee; Eliezer Masliah; Daehee Hwang; He-Jin Lee; Seung-Jae Lee
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

5.  Alpha galactosidase A activity in Parkinson's disease.

Authors:  R N Alcalay; P Wolf; O A Levy; U J Kang; C Waters; S Fahn; B Ford; S H Kuo; N Vanegas; H Shah; C Liong; S Narayan; M W Pauciulo; W C Nichols; Z Gan-Or; G A Rouleau; W K Chung; P Oliva; J Keutzer; K Marder; X K Zhang
Journal:  Neurobiol Dis       Date:  2018-02-02       Impact factor: 5.996

Review 6.  Aberrant Complement System Activation in Neurological Disorders.

Authors:  Karolina Ziabska; Malgorzata Ziemka-Nalecz; Paulina Pawelec; Joanna Sypecka; Teresa Zalewska
Journal:  Int J Mol Sci       Date:  2021-04-28       Impact factor: 5.923

7.  Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's.

Authors:  Ganqiang Liu; Brendon Boot; Joseph J Locascio; Iris E Jansen; Sophie Winder-Rhodes; Shirley Eberly; Alexis Elbaz; Alexis Brice; Bernard Ravina; Jacobus J van Hilten; Florence Cormier-Dequaire; Jean-Christophe Corvol; Roger A Barker; Peter Heutink; Johan Marinus; Caroline H Williams-Gray; Clemens R Scherzer
Journal:  Ann Neurol       Date:  2016-11       Impact factor: 10.422

Review 8.  Inflammation and immune dysfunction in Parkinson disease.

Authors:  Malú Gámez Tansey; Rebecca L Wallings; Madelyn C Houser; Mary K Herrick; Cody E Keating; Valerie Joers
Journal:  Nat Rev Immunol       Date:  2022-03-04       Impact factor: 108.555

9.  Parkinson's progression prediction using machine learning and serum cytokines.

Authors:  Diba Ahmadi Rastegar; Nicholas Ho; Glenda M Halliday; Nicolas Dzamko
Journal:  NPJ Parkinsons Dis       Date:  2019-07-25

10.  Lewy Body-like Inclusions in Human Midbrain Organoids Carrying Glucocerebrosidase and α-Synuclein Mutations.

Authors:  Junghyun Jo; Lin Yang; Hoang-Dai Tran; Weonjin Yu; Alfred Xuyang Sun; Ya Yin Chang; Byung Chul Jung; Seung-Jae Lee; Tzuen Yih Saw; Bin Xiao; Audrey Tze Ting Khoo; Lai-Ping Yaw; Jessica Jiaxin Xie; Hidayat Lokman; Wei-Yi Ong; Grace Gui Yin Lim; Kah-Leong Lim; Eng-King Tan; Huck-Hui Ng; Hyunsoo Shawn Je
Journal:  Ann Neurol       Date:  2021-08-10       Impact factor: 11.274

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.